FDA Investigator Jose Ohernandez Guzman

Jose Ohernandez Guzman has conducted inspections on 67 sites in 6 countries as of 09 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
67
Last Inspection Date:
09 Mar 2020
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, China, India, Israel, United Kingdom of Great Britain and Northern Ireland, Italy
FDA Investigators that have inspected at least one site in common with Jose Ohernandez Guzman:
Addam S Reynolds, Adena S Yau, Adetutu M Gidado, Aditi S Thakur, Alberto A Viciedo, Alice S Tsao, Allison A Aldridge, PhD, Althea A Williams, Amatul H Marium, Anastasia M Shields, Andrew Byro, Andrew J Garufi, Andrew M Abramowitz, Ann M Stewart, Anthony R Rauert, Arduino Frankovic, Arie C Menachem, Arthur G Hurst, Ashley Polizzotto, Asia D Clark, Atul J Agrawal, Barbara A Rusin, Bernice F Hirsch, Bijoy Panicker, Bo Chi, PhD, Brandy N Lepage, Bruce G Cooper, Burnell M Henry, Cameron J Smith, Carlos Chavez, Charanjeet Jassal, Charisse K Green, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Christian Parra, Christine M Rivera, Christopher S Fields, Courtney N Long, Cynthia A Palmer, Daniel L Zheng, Danna E Solorzano, Dave M Deroche, David R Delucia, Dawn L Wydner, Deborah J Parris, Demitria J Xiradakis, Devon O Seymour, Dilijeta Bajrami, Dipesh K Shah, Dongping Dai, PhD, Douglas A Campbell, Douglas G Ng, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edouard Viard, Emily A Baldwin, Erica B Brush, Erica B Raphael, Erin D Mccaffery, Felix Maldonado, Frank Verni, Frederick F Razzaghi, Gale L Glinecki, Gam S Zamil, Ganesh N Joshi, Gary J Lehr, Gary T Greco, Gregson A Joseph, Guerlain Ulysse, Harry J Brewer, Hasan A Irier, PhD, Helen B Ricalde, Ilana Zigelman, Iram R Hassan, PhD, Irina Gaberman, J'maica J Hunter, Jackson Y See, Jacobson, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James D Bridges, Jason D Tenney, Jason Kwong, Jay B Shah, Jay T Wong, Jessica L Pressley, Joey V Quitania, Jogy George, John A Podsadowski, Johnna L Bleem, Jonah S Ufferfilge, Jose Acruz Gonzalez, Jose R Hernandez, Joseph Maselli, Joy P Matthias, Juandria V Williams, Juanita P Versace, Julie D Bringger, Julie Scoma, Karen L Kosar, Karishma G Gopaul, Karl Auguste, Kathleen M Jordan, Kathryn A Nagy, Kenneth G Klobus, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kevin J Flessa, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Ricketts, Kimberly Y Smithson, Ko U Min, Kwong P Lee, Latorie S Jones, Lauren E Blaser, Lawrence W Farina, LCDR Chad N Thompson, Leiyun Boone, PhD, Liming Zhang, Lindsey M Schwierjohann, Loretta Nemchik, Lori M Newman, Luis A Dasta, Makini Cobourne Duval, PhD, Marcelo O Mangalindan, Jr, Margaret M Sands, Maria Estrella, Marie B Buen Bigornia, Marion Michaelis, Mark R Mcclain, Marlene G Swider, Marlene L Davis, Matthew B Casale, Megan A Haggerty, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Michael R Dominick, Michael R Klapal, Michael Serrano, Michele L Obert, Mindy M Chou, Mra Davism, Mra Mcculloughj, Nada F Agabani, Nailing Zhang, Nariman Patenaude, Nazmul Hassan, Nealie C Newberger, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas C Mendiola, Omadevi Somai, Investigator, Paraluman S Leonin, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul L Bellamy, Paul Mouris, Paula A Trost, Peter Abel, Peter Caparelli, Peter R Caparelli, Prabhu P Raju, Pratik S Upadhyay, DDC, Preston M Lee, Rachael A Moliver, Raihan A Chowdhury, Ramon E Martinez, Randy L Self, Raymond M Lam, Regina T Brown, Robert C Steyert, Robert J Martin, Robert R Wilson, Rochelle K Kimmel, Ronald Ifraimov, Rose Ljean Mary, Russ E Davis, Russell J Glapion, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Samuel Mindaye, Sarah A Meehan, Satheesh Thomas, Scott B Laufenberg, Sean R Marcsisin, Shantelle I Hughes, Shari L Kahn, Sharon K Pederson, Sharon K Thoma, PharmD, Sheri L Stephenson, Shirley J Berryman, Shreya Shah, Sony Mathews, Sripal R Mada, PhD, Stephanie T Durso, Steven D Kehoe, Steven J Libal, Susan W Ting, Syeda N Mahazabin, Tamara M Simpson, Tamil Arasu, PhD, Tanya R Syffrard, Thomas E Friel, Thomas J Mooney, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tonia F Bernard, Toyin B Oladimeji, Tracy M Portelli, Uduak M Inokon, Walden H Lee, Wayne E Seifert, Wayne S Fortenberry, Wendy G Tan, PhD, William J Leonard, William P Chilton, Yan Wang, Yuyan Liang, Yvesna C Blaise, Yvins Dezan, Yvonne M Santiago, Zedong Dong, Zhong Li, PhD

Jose Ohernandez Guzman's Documents

Publish Date Document Type Title
December, 2019 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2019-12-06
March, 2018 FDA 483 ImClone Systems LLC - Form 483, 2018-03-09
June, 2019 FDA 483 Infusion Options Inc. - Form 483, 2019-06-25
December, 2015 FDA 483 Advance Pharmaceutical, Inc. - Form 483, 2015-12-02
November, 2017 FDA 483 Rafa Laboratories Ltd. - Form 483, 2017-11-13
October, 2018 FDA 483 Topiderm, Inc. - Form 483, 2018-10-09
December, 2018 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2018-12-19
February, 2018 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2018-02-16
August, 2016 FDA 483 J.M. Murray Center, Inc. - Form 483, 2016-08-17
June, 2017 FDA 483 Aero Data Metal Crafters Inc - Form 483, 2017-06-06
April, 2016 FDA 483 Air Techniques Inc - Form 483, 2016-04-29
January, 2018 FDA 483 The Estee Lauder Inc - Form 483, 2018-01-26
June, 2019 FDA 483 Infusion Options, Inc. - Form 483, 2019-07-08
January, 2019 FDA 483 Tris Pharma Inc - Form 483, 2019-01-23
March, 2019 FDA 483 Yung Shin Pharm.Ind.(Kunshan) Co.,Ltd. - Form 483, 2019-03-15
February, 2018 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2018-02-16
November, 2016 FDA 483 Allegiant Health - Form 483, 2016-11-02
May, 2016 FDA 483 Velocity Pharma LLC - Form 483, 2016-05-18
April, 2018 EIR Pharbest Pharmaceuticals, Inc. - EIR, 2018-04-18
November, 2018 EIR P & L Development, LLC - EIR, 2018-11-29
March, 2019 FDA 483 Yaopharma Co., Ltd. - Form 483, 2019-03-29
June, 2017 FDA 483 Buffalo Pharmacies Inc - Form 483, 2017-06-23
December, 2015 FDA 483 Buffalo Dental Manufacturing Co., Inc. - Form 483, 2015-12-22
June, 2017 EIR Aero Data Metal Crafters Inc - EIR, 2017-06-06
January, 2016 FDA 483 Topiderm, Inc. - Form 483, 2016-01-21
June, 2017 FDA 483 Response Aero Data Metal Crafters Inc - Form 483R, 2017-06-06
July, 2017 EIR Alexion Pharmaceuticals, Inc. - EIR, 2017-07-21
September, 2017 FDA 483 ALK-ABELLO, INC. - Form 483, 2017-09-19
December, 2018 EIR InvaGen Pharmaceuticals, Inc - EIR, 2018-12-19
September, 2019 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2019-09-03
March, 2017 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2017-03-30
June, 2016 FDA 483 Huber Soda, LLC (DBA Natrium Products) - Form 483, 2016-06-30
November, 2018 FDA 483 P & L Development, LLC - Form 483, 2018-11-13
April, 2018 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2018-04-18
July, 2017 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2017-07-21
March, 2018 FDA 483 Response ImClone Systems LLC - Form 483R, 2018-03-27
December, 2019 EIR InvaGen Pharmaceuticals, Inc - EIR, 2019-12-06
March, 2019 FDA 483 NingBo Huize Commodity Co.,Ltd. - Form 483, 2019-03-22
May, 2018 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2018-05-29
March, 2016 FDA 483 MSKCC RMIPC - Form 483, 2016-03-29
May, 2017 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2017-05-05
May, 2018 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2018-05-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more